These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 14358776)

  • 1. [Iron therapy].
    OSSIPOWSKI B
    Sem Hop; 1955 Mar; 31(14):802-5. PubMed ID: 14358776
    [No Abstract]   [Full Text] [Related]  

  • 2. Splenectomy in three cases of myelophthisic anaemia.
    MERSKEY C; BUDTZ-OLSEN OE
    Br Med J; 1953 Sep; 2(4835):537-40. PubMed ID: 13082030
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of osteomyelosclerosis and osteomyelofibrosis].
    Treske U
    Dtsch Med Wochenschr; 1970 Aug; 95(33):1691-2. PubMed ID: 5447788
    [No Abstract]   [Full Text] [Related]  

  • 4. [The favorable effect of cortisone in severe erythroleukemic anemia].
    VAJDA L
    Orv Hetil; 1953 Jun; 94(25):675-8. PubMed ID: 13088059
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of anemic crises in osteo- and myelo-sclerosis with corticosteroid hormones].
    KHASANOVA KA
    Vopr Onkol; 1961 Jun; 6():31-4. PubMed ID: 13755651
    [No Abstract]   [Full Text] [Related]  

  • 6. The response to adrenalectomy of a leucoerythroblastic process due to metastatic carcinoma of breast.
    FRASER ID; TALBOT CH
    Lancet; 1961 Apr; 1(7179):690-3. PubMed ID: 13701511
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bone marrow damage in virus hepatitis].
    Spatz R; Borchers HG; Zobl H
    Med Klin; 1968 Nov; 63(44):1761-5. PubMed ID: 5704507
    [No Abstract]   [Full Text] [Related]  

  • 8. Leukoerythroblastic anemia due to oxalosis with extensive bone marrow involvement.
    Tapia G; Navarro JT; Navarro M
    Am J Hematol; 2008 Jun; 83(6):515-6. PubMed ID: 17636470
    [No Abstract]   [Full Text] [Related]  

  • 9. [Erythroleukemia with hemoglobin disorders and disorders of iron metabolism].
    HITZIG WH; SCHMID M; BETKE K; ROTHSCHILD M
    Helv Paediatr Acta; 1960 Aug; 15():203-22. PubMed ID: 13714687
    [No Abstract]   [Full Text] [Related]  

  • 10. [A new sensible iron therapy with a new iron preparation as shown in oral iron loading tests].
    JORGENSEN G
    Arztl Wochensch; 1955 Jan; 10(4):82-4. PubMed ID: 14349812
    [No Abstract]   [Full Text] [Related]  

  • 11. Ascorbic acid deficiency may be a cause of refractoriness to iron-therapy in the treatment of iron-deficiency anemia.
    Cacciola E; Consoli U; Giustolisi R; Cacciola E
    Haematologica; 1994; 79(1):96-7. PubMed ID: 15378958
    [No Abstract]   [Full Text] [Related]  

  • 12. [Myelophthisic anemia with myeloid metaplasia; report of 3 cases].
    BREGNBALLE G; VAD E
    Ugeskr Laeger; 1958 Jul; 120(30):983-5. PubMed ID: 13581313
    [No Abstract]   [Full Text] [Related]  

  • 13. Benefits and risks of iron therapy for chronic anaemias.
    Weiss G; Gordeuk VR
    Eur J Clin Invest; 2005 Dec; 35 Suppl 3():36-45. PubMed ID: 16281957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of iron therapy on cognition in anemic school going boys.
    Bandhu R; Shankar N; Tandon OP; Madan N
    Indian J Physiol Pharmacol; 2003 Jul; 47(3):301-10. PubMed ID: 14723316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron supplementation during treatment with erythropoiesis-stimulating agents for cancer-related anemia.
    Schiavetto I; Pedrazzoli P; Basilico V; Siena S
    Chemotherapy; 2008; 54(6):417-20. PubMed ID: 18824846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction to "A road map for intravenous iron and anemia management: preparing for the future".
    Coyne DW
    Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S1-4. PubMed ID: 19010256
    [No Abstract]   [Full Text] [Related]  

  • 17. A comprehensive vision for intravenous iron therapy.
    Coyne DW
    Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S14-20. PubMed ID: 19010257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A young women with hypochromic microcytotic anemia unresponsive to iron therapy].
    Järveläinen H; Juvonen V; Pelliniemi TT
    Duodecim; 2004; 120(1):80-3. PubMed ID: 14976812
    [No Abstract]   [Full Text] [Related]  

  • 19. Anemia is an important finding and is likely to respond to iron therapy.
    Wright CM; Summerfield GP; Moy R
    Pediatrics; 2005 Nov; 116(5):1258-9; author reply 1259. PubMed ID: 16264019
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravenous iron: from anathema to standard of care.
    Auerbach M; Coyne D; Ballard H
    Am J Hematol; 2008 Jul; 83(7):580-8. PubMed ID: 18273906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.